.svg){kind=icon}
October is Breast Cancer Awareness Month—a time to emphasize education, screening, early detection, and support for people living with breast cancer.
Breast cancer is one of the most widely recognized cancers, but awareness involves more than wearing pink. Understanding personal risk, keeping up with appropriate screening, recognizing changes that deserve medical attention, and having informed conversations with healthcare professionals can all play an important role in breast health.
For Florida medical cannabis patients, another question may arise: Where does medical cannabis fit into cancer care?
The answer requires an important distinction.
Medical cannabis should not be presented as a treatment for breast cancer. Cannabis and cannabinoids are being researched in oncology, and some patients discuss them with healthcare professionals for management of certain cancer- or treatment-related symptoms. They do not replace chemotherapy, radiation therapy, surgery, immunotherapy, endocrine therapy, targeted therapy, or other evidence-based cancer treatments.
Understanding Breast Cancer
Breast cancer begins when cells in breast tissue grow abnormally and begin dividing without normal controls.
There is not one single type of breast cancer.
Tumors can differ according to characteristics such as:
- Hormone receptor status
- HER2 status
- Genetic changes
- Location
- Stage
- Whether cancer has spread beyond the breast
These biological differences are important because modern breast cancer treatment is increasingly individualized.
Two people with breast cancer may receive very different treatment plans based on their diagnosis.
This is also why decisions about complementary therapies—including medical cannabis—should be made in the context of the patient's complete medical history and oncology treatment plan.
Why Early Detection Matters
Screening is designed to identify breast cancer before symptoms appear.
Mammography remains a central breast cancer screening tool.
Screening schedules can differ according to age, personal history, family history, genetics, breast density, and other risk factors. People at higher risk may require different screening strategies, potentially including breast MRI in addition to mammography.
Rather than assuming one schedule applies to everyone, patients should discuss their individual risk and screening plan with their healthcare provider.
Breast Cancer Awareness Month can be a useful reminder to check whether recommended screening is up to date.
Know What Is Normal for You
Screening does not replace awareness of changes in the breast.
A new breast lump is one possible symptom, but breast cancer can present in other ways.
Changes that should be discussed with a healthcare professional can include:
- A new breast or underarm lump
- Swelling of part or all of the breast
- Changes in breast size or shape
- Skin dimpling or puckering
- Nipple changes or retraction
- Unexplained nipple discharge
- Persistent breast or nipple pain
- Red, thickened, flaky, or irritated skin
- Swollen lymph nodes near the underarm or collarbone
Many breast changes are caused by conditions other than cancer.
The important point is not to diagnose a change yourself. New or unexplained breast changes deserve professional evaluation.
Breast Cancer Can Affect More Than the Breast
A cancer diagnosis can affect nearly every part of daily health.
Patients undergoing treatment may experience symptoms related to the disease itself, treatment, medications, surgery, or emotional stress.
Depending on the treatment plan, patients may experience issues such as:
- Nausea
- Appetite changes
- Fatigue
- Sleep disruption
- Pain
- Anxiety
- Changes in concentration
- Neuropathy
- Changes in body image
- Treatment-related menopause symptoms
Supportive care is an important part of oncology.
The goal is to help patients manage symptoms and maintain quality of life while cancer-directed treatment addresses the disease.
Where Medical Cannabis Fits Into the Conversation
Cancer is one of the qualifying medical conditions under Florida's medical marijuana program.
That does not mean medical cannabis is considered a treatment for cancer itself.
A qualified Florida physician must determine whether medical marijuana is appropriate for an individual patient.
Cannabis and cannabinoids have been studied for several symptoms that can occur in people receiving cancer treatment, including:
- Nausea and vomiting
- Pain
- Appetite loss
- Sleep difficulties
The strength of evidence differs considerably depending on the symptom, cannabinoid, formulation, and route of administration.
Patients should avoid interpreting general cannabis research as evidence that a particular dispensary product will produce the same results.
Cannabis Does Not Treat Breast Cancer
This point deserves to be stated clearly.
There is laboratory research investigating how cannabinoids interact with cancer cells and biological pathways.
Researchers have studied processes such as:
- Cell signaling
- Inflammation
- Cell proliferation
- Apoptosis
- The endocannabinoid system
- Tumor biology
Laboratory findings can help scientists identify possible areas for future clinical research.
However, demonstrating an effect on cancer cells in a laboratory dish or animal model does not establish that cannabis treats breast cancer in humans.
Medical cannabis should not be substituted for established cancer treatment.
Patients should be especially cautious of claims that THC, CBD, cannabis oil, terpenes, or other cannabis compounds can cure, shrink, or eliminate breast cancer.
Cannabis and Chemotherapy-Related Nausea
One of the better-studied areas of cannabinoid medicine involves chemotherapy-induced nausea and vomiting.
Prescription cannabinoid medications such as dronabinol and nabilone have been approved for certain patients experiencing chemotherapy-related nausea and vomiting that has not adequately responded to standard treatments.
That is different from saying all cannabis products are proven anti-nausea therapies.
Modern oncology also has several established antiemetic medications.
Patients experiencing nausea during cancer treatment should first discuss symptoms with their oncology team so the cause can be evaluated and appropriate treatment selected.
Pain and Cancer Care
Pain associated with cancer can have many causes.
It may result from:
- The tumor itself
- Surgery
- Radiation
- Neuropathy
- Musculoskeletal changes
- Treatment-related inflammation
- Other unrelated medical conditions
Cannabinoids have been investigated for pain, including cancer-related pain, but evidence varies considerably.
Cancer pain should be evaluated clinically rather than treated solely based on a product's THC percentage, terpene profile, or marketing description.
Persistent or rapidly changing pain can provide important medical information and should be reported to the treating team.
Breast Cancer Treatment and Medication Interactions
This is particularly important for breast cancer patients.
Cancer treatment may involve combinations of medications, including:
- Chemotherapy
- Hormonal or endocrine therapy
- Targeted medications
- Immunotherapy
- Pain medications
- Anti-nausea medications
- Antidepressants or anti-anxiety medications
- Sleep medications
- Blood thinners
THC, CBD, and other cannabis compounds can influence enzymes involved in drug metabolism.
That creates the possibility of medication interactions.
The significance depends on the cannabis product, cannabinoid concentration, dose, route, and medications being taken.
Patients using or considering medical cannabis should therefore tell their oncologist, pharmacist, and qualified medical marijuana physician what they are taking.
More THC Is Not Necessarily Better
Cancer patients may be particularly vulnerable to unwanted effects from high doses of THC.
Possible effects can include:
- Dizziness
- Drowsiness
- Anxiety
- Impaired coordination
- Changes in concentration
- Memory impairment
- Increased heart rate
- Intoxication
These effects may become more important when someone is already experiencing treatment-related fatigue, weakness, dehydration, or medication side effects.
Increasing THC concentration does not automatically produce better symptom control.
Individual response and dose matter.
What About CBD?
CBD is frequently marketed with broad wellness and health claims.
Patients should approach those claims cautiously.
CBD is pharmacologically active and can interact with drug-metabolizing enzymes. High doses may be especially relevant when someone is taking multiple prescription medications.
CBD should therefore be included when patients discuss supplements, cannabis products, and medications with their oncology team.
“Non-intoxicating” does not mean biologically inactive or interaction-free.
Questions to Ask Your Healthcare Team
Patients considering medical cannabis during breast cancer treatment may find it helpful to ask:
- Could cannabis interact with any of my cancer medications?
- Which symptoms should be managed with conventional treatment first?
- Are there reasons I should avoid THC or CBD?
- Could cannabis worsen dizziness, sedation, or cognitive side effects?
- Does my treatment affect which administration routes are appropriate?
- How should I monitor whether a supportive treatment is actually helping?
- Which symptoms should prompt immediate medical attention?
Keeping the oncology team informed allows cannabis use to be considered as part of the complete treatment picture.
Breast Cancer Awareness Is About Informed Care
Breast Cancer Awareness Month is ultimately about helping people make informed health decisions.
That includes understanding screening, recognizing changes, obtaining appropriate medical evaluation, and relying on evidence-based cancer care.
For Florida patients who qualify for medical cannabis, cannabis may become part of a broader conversation about symptom management.
But the distinction should remain clear:
Medical cannabis may be discussed as supportive care for some patients. It should not be presented as a treatment for breast cancer.
Working openly with oncologists, pharmacists, and qualified physicians is the safest way to integrate any complementary approach into cancer care.